Literature DB >> 15221939

Protein expression profiles in adenocarcinomas and squamous cell carcinomas of the lung generated using tissue microarrays.

Reinhard Ullmann1, Patrizia Morbini, Iris Halbwedl, Massimo Bongiovanni, Margit Gogg-Kammerer, Mauro Papotti, Sabine Gabor, Heiko Renner, Helmut Hans Popper.   

Abstract

With the appearance of defect-targeted therapies, the definition of tumour protein expression profiles has gained increasing importance. Two lung carcinoma tissue microarrays, one including 75 primary adenocarcinomas (ACs) and the other comprising 67 primary squamous cell carcinomas (SQCCs), were generated in the present study. On both arrays, each tumour was represented by an average of five cores. In addition, one punch of normal lung parenchyma adjacent to each tumour was included in the array. Immunohistochemical expression of 86 proteins was evaluated and the results were analysed by non-parametric tests, hierarchical clustering, and principal component analysis. In both tumour entities, parenchyma and tumours were clearly separated by hierarchical clustering. By the same statistical approach, it was possible to distinguish ACs from SQCCs with 98% accuracy and to distinguish parenchyma adjacent to ACs from that adjacent to SQCCs with 96% accuracy. It was also possible to separate ACs into three groups that significantly differed in survival. Cathepsin E and hsp105 were identified as previously unknown predictors of survival in lung AC. In summary, this study has shown that protein profiles are feasible tools for anticipating biological behaviour. Copyright 2004 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221939     DOI: 10.1002/path.1584

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  Selective detection of Cathepsin E proteolytic activity.

Authors:  Wael R Abd-Elgaliel; Ching-Hsuan Tung
Journal:  Biochim Biophys Acta       Date:  2010-06-19

2.  Intermolecular complementation achieves high-specificity tumor targeting by anthrax toxin.

Authors:  Shihui Liu; Vivien Redeye; Jeffrey G Kuremsky; Marissa Kuhnen; Alfredo Molinolo; Thomas H Bugge; Stephen H Leppla
Journal:  Nat Biotechnol       Date:  2005-05-15       Impact factor: 54.908

3.  Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection.

Authors:  Edmund J Keliher; Thomas Reiner; Sarah Earley; Jenna Klubnick; Carlos Tassa; Andrew J Lee; Sridhar Ramaswamy; Nabeel Bardeesy; Douglas Hanahan; Ronald A Depinho; Cesar M Castro; Ralph Weissleder
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

4.  Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors.

Authors:  Anthony J O'Donoghue; Sam L Ivry; Chaity Chaudhury; Daniel R Hostetter; Douglas Hanahan; Charles S Craik
Journal:  Biol Chem       Date:  2016-09-01       Impact factor: 3.915

Review 5.  Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.

Authors:  Corbin Pontious; Sabrina Kaul; Marcus Hong; Phil A Hart; Somashekar G Krishna; Luis F Lara; Darwin L Conwell; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2019-09-20       Impact factor: 3.996

6.  The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung.

Authors:  Esther Conde; Bárbara Angulo; Pilar Redondo; Oscar Toldos; Elena García-García; Ana Suárez-Gauthier; Belén Rubio-Viqueira; Carmen Marrón; Ricardo García-Luján; Montse Sánchez-Céspedes; Angel López-Encuentra; Luis Paz-Ares; Fernando López-Ríos
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

7.  Protease-activated drug development.

Authors:  Ki Young Choi; Magdalena Swierczewska; Seulki Lee; Xiaoyuan Chen
Journal:  Theranostics       Date:  2012-02-08       Impact factor: 11.556

8.  Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development.

Authors:  Hongye Liu; Alvin T Kho; Isaac S Kohane; Yao Sun
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

9.  High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.

Authors:  Oliver M Fisher; Angelique J Levert-Mignon; Sarah J Lord; Natalia K Botelho; Araluen K Freeman; Melissa L Thomas; Dan Falkenback; Antony Wettstein; David C Whiteman; Yuri V Bobryshev; Reginald V Lord
Journal:  Ann Surg Oncol       Date:  2014-10-28       Impact factor: 5.344

Review 10.  Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening.

Authors:  Dean H Conrad; Jesse Goyette; Paul S Thomas
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.